Identification of a cranberry juice product that inhibits enteric CYP3A-mediated first-pass metabolism in humans.
about
Physiologically based pharmacokinetic modeling framework for quantitative prediction of an herb-drug interaction.The warfarin-cranberry juice interaction revisited: A systematic in vitro-in vivo evaluation.Isolation and identification of intestinal CYP3A inhibitors from cranberry (Vaccinium macrocarpon) using human intestinal microsomes.Influence of dietary substances on intestinal drug metabolism and transport.Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.Impact of organic solvents on cytochrome P450 probe reactions: filling the gap with (S)-Warfarin and midazolam hydroxylationSuspected Interaction of Cranberry Juice Extracts and Tacrolimus Serum Levels: A Case Report.Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers.Semisynthesis, cytotoxicity, antiviral activity, and drug interaction liability of 7-O-methylated analogues of flavonolignans from milk thistle.A systematic approach to evaluate herb-drug interaction mechanisms: investigation of milk thistle extracts and eight isolated constituents as CYP3A inhibitors.Herb-drug pharmacokinetic interactions reviewed.Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences.Chemistry, Pharmacology and Health Benefits of Anthocyanins.Effect of standardized cranberry extract on the activity and expression of selected biotransformation enzymes in rat liver and intestine.In vitro inhibition of human CYP1A2, CYP2D6, and CYP3A4 by six herbs commonly used in pregnancy.Identification of Intestinal UDP-Glucuronosyltransferase Inhibitors in Green Tea (Camellia sinensis) Using a Biochemometric Approach: Application to Raloxifene as a Test Drug via In Vitro to In Vivo Extrapolation.
P2860
Q33702513-F2D1DB33-5C18-460F-8735-33D94F5D5624Q34145180-6225FD6B-6BA1-470B-B34E-3DC6596C2DDAQ34504635-C38803D6-CDDF-444B-B309-E86A773A6A4AQ34553835-E914A8FE-6CE6-4F00-96DD-A6F368C8F326Q36303746-C42F496E-7618-411F-A501-C02EFD0ECB8BQ36335452-331B5DBE-70B0-41ED-9CB5-CA528607997BQ37014290-AB3C4D59-CFFE-4BA1-AE9C-46EDCD15E44FQ37334396-CDE8AB5C-A946-404B-B24D-30F976C7BA60Q37374001-338DEB92-BB5E-4BCC-BCB7-B6D7C46826C5Q37422735-636F3730-B166-4902-9FFB-77653D25CFE1Q37808478-1961BE09-84CC-458C-B2E6-22757C9A4814Q38574619-DFB73C30-372A-4B39-B1D8-352A72511DDDQ38843382-6090AEFB-091E-48C6-A631-77C9F5FBB6AAQ41733187-545CBF12-44B5-41F0-8EE2-3A6261DC6E17Q45808951-A9A29C20-5FAC-49F3-B947-976EC7737A6DQ50146193-F6AE8D41-D670-4B99-986A-D1644B106537
P2860
Identification of a cranberry juice product that inhibits enteric CYP3A-mediated first-pass metabolism in humans.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification of a cranberry ...... rst-pass metabolism in humans.
@en
Identification of a cranberry ...... rst-pass metabolism in humans.
@nl
type
label
Identification of a cranberry ...... rst-pass metabolism in humans.
@en
Identification of a cranberry ...... rst-pass metabolism in humans.
@nl
prefLabel
Identification of a cranberry ...... rst-pass metabolism in humans.
@en
Identification of a cranberry ...... rst-pass metabolism in humans.
@nl
P2093
P2860
P356
P1476
Identification of a cranberry ...... irst-pass metabolism in humans
@en
P2093
Angela D M Kashuba
Daniel R Carrizosa
E Claire Dees
Mary F Paine
Zhixia Yan
P2860
P304
P356
10.1124/DMD.108.024968
P577
2008-12-29T00:00:00Z